Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space ...

In a report released today, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Milestone Pharmaceuticals (MIST – Research ...

episodes classified as atrial tachycardia. The AF Suppression Algorithm reduced symptomatic AF burden from 2.50% in the control group to 1.87% in the treatment group, a relative difference of 25%.

This innovative, all-in-one system combines high-density (HD) mapping with pulsed-field (PF) and radiofrequency (RF) ablation capabilities for the treatment of persistent atrial fibrillation (AFib ...

In September 2024, secured CMS coverage (Category B) of the vCLAS™ ultra-low temperature cryoablation catheter as a part of FULCRUM-VT Pivotal IDE study for treatment of drug-resistant ventricular ...

Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and provided ...

The 1-year freedom from atrial fibrillation, atrial tachycardia, or atrial flutter recurrence ... were consistent with those observed in the earlier INSPIRE (Study for Treatment of Paroxysmal Atrial ...

This can initiate ventricular arrhythmias like polymorphic ventricular tachycardia (PMVT ... postpartum cardiomyopathy s/p Bi-V CRT-D (Boston Scientific G124), and paroxysmal atrial fibrillation ...

You have to manage your heart health to maintain a healthy life even when you get older. According to the recently released ...

And that’s most common in paroxysmal ... For atrial fibrillation ablation, you are typically looking for full-thickness transmural lesions that are also contiguous. You do not want to leave gaps in ...